Claims for Patent: RE47221

Summary for Patent: RE47221

Title:	Tricyclic compounds
Abstract:	The invention provides compounds of Formula (I) and Formula (II) ##STR00001## pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Inventor(s):	Wishart; Neil (Jefferson, MA), Frank; Kristine E. (Grayslake, IL), Friedman; Michael (Kennebunkport, ME), George; Dawn M. (Charlton, MA), Stewart; Kent D. (Charlotte, NC), Wallace; Grier A. (Sterling, MA)
Assignee:	AbbVie Inc. (North Chicago, IL)
Application Number:	15/446,102
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent RE47221
Patent Claims:	1. A compound selected from ##STR01444## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .[.2. A compound represented by the following structure: ##STR01445## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .[.3. A compound represented by the following structure: ##STR01446## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .[.4. A compound represented by the following structure: ##STR01447## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .[.5. A compound represented by the following structure: ##STR01448## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .[.6. A compound selected from ##STR01449## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .[.7. A compound represented by the following structure: ##STR01450## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .[.8. A compound represented by the following structure: ##STR01451## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .[.9. A compound represented by the following structure: ##STR01452## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .[.10. A compound selected from ##STR01453## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .[.11. A compound represented by the following structure: ##STR01454## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .[.12. A compound represented by the following structure: ##STR01455## or pharmaceutically acceptable salts, stereoisomers and isomers thereof..]. .Iadd.13. A compound represented by the following structure: ##STR01456## or a pharmaceutically acceptable salt thereof..Iaddend. .Iadd.14. The compound according to claim 13 represented by the following structure: ##STR01457## .Iaddend.